Canopy Growth Corp
CGCNasdaqHealthcare · Medicinal Chemicals & Botanical Products · Z4 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-K/Amissed a reporting deadline ↗Jun 14, 2023
- NT 10-Kmissed a reporting deadline ↗May 26, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Yanofsky TheresaDirector | Mar 31, 2026 | Sell | 10,373 | $0.93 |
| Atkins M ShanDirector | Mar 31, 2026 | Sell | 2,074 | $0.93 |
| Bayern JosephDirector | Mar 31, 2026 | Sell | 2,658 | $0.93 |
| Lazzarato David AngeloDirector | Mar 31, 2026 | Sell | 15,624 | $0.93 |
| Mongeau LucOfficer — Chief Executive Officer | Feb 11, 2026 | Sell | 9,376 | $1.06 |
| Yanofsky TheresaDirector | Dec 31, 2025 | Sell | 10,434 | $1.13 |
| Lazzarato David AngeloDirector | Dec 31, 2025 | Sell | 15,715 | $1.13 |
| Bayern JosephDirector | Nov 11, 2025 | Grant | 42,658 | $0.00 |
| Lazzarato David AngeloDirector | Sep 29, 2025 | Sell | 15,677 | $1.58 |
| Atkins M ShanDirector | Sep 29, 2025 | Sell | 2,216 | $1.58 |
| Yanofsky TheresaDirector | Sep 29, 2025 | Sell | 10,408 | $1.58 |
| Kruh WillyDirector | Sep 29, 2025 | Sell | 10,451 | $1.58 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 23.0M | 3.7 | -9.8% |
| Apr 30, 2026 | 25.5M | 1.3 | -5.1% |
| Apr 15, 2026 | 26.9M | 2.7 | +0.6% |
| Mar 31, 2026 | 26.7M | 3.8 | +6.6% |
| Mar 13, 2026 | 25.1M | 3.4 | -6.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylawsMay 27, 2026
- Prior financials not reliable (restatement) · Regulation FD disclosureMay 15, 2026
- Regulation FD disclosure · Other material eventMar 16, 2026
- Results of operationsFeb 6, 2026
- Entered a material agreement · New financial obligation · Unregistered equity sale · Regulation FD disclosure · Other material eventJan 8, 2026
- Entered a material agreement · Unregistered equity sale · Director / officer change · Regulation FD disclosure · Other material eventDec 15, 2025
- Results of operationsNov 7, 2025
- Shareholder voteOct 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDJun 1, 2026
- 8-KFORM 8-KMay 27, 2026
- 8-KFORM 8-KMay 15, 2026
- 4OWNERSHIP DOCUMENTApr 2, 2026
- 4OWNERSHIP DOCUMENTApr 2, 2026
- 4OWNERSHIP DOCUMENTApr 2, 2026
- 4OWNERSHIP DOCUMENTApr 2, 2026
- 8-KFORM 8-KMar 16, 2026
- EFFECTFeb 13, 2026
- 424B3Feb 13, 2026
- 4OWNERSHIP DOCUMENTFeb 12, 2026
- CORRESPFeb 12, 2026
- UPLOADFeb 12, 2026
- S-3Feb 6, 2026
- 8-KFeb 6, 2026